Description

Lanatoside C is a cardiac glycoside compound derived from the leaves of *Digitalis lanata*, known for its potent pharmacological activity. This high-purity intermediate is critical for the research and development of cardiovascular therapeutics and serves as a key reference standard in analytical chemistry. It is primarily utilized by pharmaceutical R&D laboratories, biotechnology companies, and academic institutions focused on cardiology and natural product chemistry.

Application

• Pharmaceutical Reference Standard: Used as a certified reference material (CRM) for the identification, purity assessment, and quantification of cardiac glycosides in drug substances and finished products via HPLC, LC-MS, and other analytical methods.
• Active Pharmaceutical Ingredient (API) Intermediate: Serves as a crucial precursor in the synthesis and semi-synthesis of other potent cardiac glycosides and related therapeutic agents.
• Biochemical Research: Employed in in-vitro and in-vivo studies to investigate the mechanisms of action, pharmacokinetics, and structure-activity relationships (SAR) of cardiac glycosides on sodium-potassium ATPase pumps.
• Quality Control & Assurance: Essential for pharmaceutical QC laboratories to validate analytical methods, ensure batch-to-batch consistency, and comply with regulatory guidelines (e.g., ICH, USP).
• Natural Product Isolation & Standardization: Used as a marker compound for the standardization of *Digitalis* plant extracts and related botanical preparations.

Basic Information

Product Name	Lanatoside C
CAS No.	17575-22-3
Molecular Formula	C49H76O20
Molecular Weight	985.11 g/mol
Synonyms	Lanatoside C; Digilanide C; α-Acetyldigoxin; 3β-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12β,14-dihydroxy-5β-card-20(22)-enolide 16-acetate; Digitalis lanata glycoside C; (3β,5β,12β)-3-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide 16-acetate
EINECS	Contact for details

Quality Control

Our Lanatoside C is manufactured under strict quality management systems to ensure it meets the exacting standards required for pharmaceutical research and development. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles as determined by advanced chromatographic techniques. We support compliance with relevant pharmacopeial guidelines (e.g., USP) for reference standards.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a desiccated environment to maintain stability and purity. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Water Content (KF)	≤2.0%
Residue on Ignition	≤0.1%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.